The first concerns safety and the second effectiveness, with testing on a small number of people.
According to Lancet report, in phases one and two trails, the vaccine did not lead to side effects in 76 volunteers. Phase-2 and 3 bridging studies have been initiated by the ICMR at 14 clinical trial sites, the minister said.
"We already face challenges with vaccine acceptance for many proven vaccines", World Health Organization chief Tedros Adhanom Ghebreyesus said in pre-recorded comments, as he spoke about the push to rapidly develop vaccines.
Haddad said that testing of the vaccine developed by the University of Oxford was halted on September 9 in the third stage after reports of serious side effects during clinical trials. However, these preliminary results also listed the adverse effects of the vaccine. It is expected that at least 50 per cent of this would be meant for supplies within India.
Most adverse events were mild, and no serious adverse events were detected within 42 days of vaccination.
At least eight candidate vaccines being developed in India.
Bale poised to end Madrid nightmare
All of the players who play for Madrid are aware of the club they're joining and I think that he's proved his ability. Number 9 at Tottenham is now vacant, with Harry Winks holding the number 8 shirt and Harry Kane the number 10 shirt.
Addressing the Parliament, Health Minister Dr Harsh Vardhan said, "ICMR and SII (Serum Institute of India) have partnered for clinical development of a glycol-protein sub-unit nanoparticle adjuvanted vaccine developed by Novavax from USA".
As reported, Murashko said that the symptoms after being injected with the Russian COVID-19 vaccine "level off" by the next day and the complications are "described in the instructions and are predictable".
Regarding the price of the vaccine, he said it could not be predicted as of now.
The Electronic Vaccine Intelligence Network (eVIN) system, which provides real-time information on vaccine stocks and storage temperatures across all cold chain points in the country, is being enhanced to address the needs for distribution and tracking of Covid-19 vaccine, whenever it becomes available, the Rajya Sabha was informed on Sunday.
Meanwhile, Hyderabad-based GV Prasad-helmed Dr Reddy's Laboratories (Dr Reddy's) and the Russian Direct Investment Fund (RDIF) are planning to roll out the coronavirus vaccine as early as November.
Russian diplomats have been busy in Cairo, meeting with Egyptian officials and the local media to promote the so-called Sputnik V, a vaccine developed by Moscow's Gamaleya Institute - even though clinical trials have not been completed on the drug, and the Chinese seem to be spreadheing the race for an greement with Egypt. Under the circumstances, the Russian vaccine could be India's best bet to save millions of lives, provided the notorious Indian red tape is not allowed to impede the process.